• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫内节育器使用的新进展:聚焦美国。

New developments in intrauterine device use: focus on the US.

作者信息

Nelson Anita L, Massoudi Natasha

机构信息

Department of Obstetrics and Gynecology, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, CA, USA.

American University of the Caribbean School of Medicine, Cupecoy, Sint Maarten.

出版信息

Open Access J Contracept. 2016 Sep 13;7:127-141. doi: 10.2147/OAJC.S85755. eCollection 2016.

DOI:10.2147/OAJC.S85755
PMID:29386944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5683151/
Abstract

Many more women in the US today rely upon intrauterine devices (IUDs) than in the past. This increased utilization may have substantially contributed to the decline in the percentage of unintended pregnancies in the US. Evidence-based practices have increased the number of women who are medically eligible for IUDs and have enabled more rapid access to the methods. Many women enjoy freedom to use IUDs without cost, but for many the impact of the Affordable Care Act has yet to be realized. Currently, there are three hormonal IUDs and one copper IUD available in the US. Each IUD is extremely effective, convenient, and safe. The newer IUDs have been tested in populations not usually included in clinical trials and provide reassuring answers to older concerns about IUD use in these women, including information about expulsion, infection, and discontinuation. On the other hand, larger surveillance studies have provided new estimates about the risks of complications such as perforation, especially in postpartum and breastfeeding women. This article summarizes significant features of each IUD and provides a summary of the differences to aid clinicians in the US and other countries in advising women about IUD choices.

摘要

如今,美国使用宫内节育器(IUD)的女性比过去多得多。这种使用率的提高可能在很大程度上促使美国意外怀孕率下降。循证实践增加了符合医学条件使用IUD的女性数量,并使她们能更快获得这些避孕方法。许多女性可免费使用IUD,但对许多人来说,《平价医疗法案》的影响尚未显现。目前,美国有三种激素IUD和一种铜IUD可供使用。每种IUD都极其有效、方便且安全。新型IUD已在通常不纳入临床试验的人群中进行了测试,并为过去对这些女性使用IUD的担忧提供了可靠答案,包括有关排出、感染和停用的信息。另一方面,规模更大的监测研究对诸如穿孔等并发症的风险给出了新的评估,尤其是在产后和哺乳期女性中。本文总结了每种IUD的显著特点,并概述了差异,以帮助美国和其他国家的临床医生为女性提供有关IUD选择的建议。

相似文献

1
New developments in intrauterine device use: focus on the US.宫内节育器使用的新进展:聚焦美国。
Open Access J Contracept. 2016 Sep 13;7:127-141. doi: 10.2147/OAJC.S85755. eCollection 2016.
2
Intrauterine devices: an effective alternative to oral hormonal contraception.宫内节育器:口服激素避孕的有效替代方法。
Prescrire Int. 2009 Jun;18(101):125-30.
3
The safety of intrauterine devices among young women: a systematic review.年轻女性使用宫内节育器的安全性:一项系统综述。
Contraception. 2017 Jan;95(1):17-39. doi: 10.1016/j.contraception.2016.10.006. Epub 2016 Oct 19.
4
Statement on intrauterine devices (IUDs).关于宫内节育器(IUDs)的声明。
IPPF Med Bull. 1987 Dec;21(6):3-5.
5
Intrauterine devices. The optimal long-term contraceptive method?宫内节育器。最佳的长期避孕方法?
J Reprod Med. 1999 Mar;44(3):269-74.
6
Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.左炔诺孕酮宫内节育器与铜宫内节育器的避孕效果比较:欧洲宫内节育器主动监测研究
Contraception. 2015 Apr;91(4):280-3. doi: 10.1016/j.contraception.2015.01.011. Epub 2015 Jan 16.
7
Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.宫内节育器相关的子宫穿孔和排出风险。
Obstet Gynecol. 2023 Sep 1;142(3):641-651. doi: 10.1097/AOG.0000000000005299. Epub 2023 Aug 3.
8
Acceptability of an experimental intracervical device: results of a study controlling for selection bias.一种实验性子宫颈内装置的可接受性:一项控制选择偏倚研究的结果
Contraception. 1989 Jan;39(1):73-84. doi: 10.1016/0010-7824(89)90016-4.
9
Postpartum IUDS: keys for success.产后宫内节育器:成功的关键
Contraception. 1992 Apr;45(4):351-61. doi: 10.1016/0010-7824(92)90057-z.
10
Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.产后即刻植入 GYNE-T 380 和 GYNE-T 380 产后宫内节育器:随机研究。
Am J Obstet Gynecol. 1996 Nov;175(5):1231-5. doi: 10.1016/s0002-9378(96)70033-9.

引用本文的文献

1
Non-hormonal Contraception: Current and Emerging Targets.非激素避孕:当前及新出现的靶点
Adv Exp Med Biol. 2025;1469:245-272. doi: 10.1007/978-3-031-82990-1_11.
2
Healthcare providers' perceptions on post abortion intrauterine contraception: A qualitative study in central Uganda.医疗服务提供者对人工流产后宫内避孕的看法:乌干达中部的一项定性研究
PLoS One. 2024 Dec 5;19(12):e0301748. doi: 10.1371/journal.pone.0301748. eCollection 2024.
3
Contraception Choice for Female Endurance Athletes: What's Sport Got to Do With It? A Cross-Sectional Survey.女性耐力运动员的避孕选择:运动与之有何关系?一项横断面调查。
Sports Med. 2024 Dec;54(12):3181-3197. doi: 10.1007/s40279-024-02078-1. Epub 2024 Sep 1.
4
A Novel Intrauterine Device for the Spatio-Temporal Release of Norethindrone Acetate as a Counter-Estrogenic Intervention in the Genitourinary Syndrome of Menopause.一种用于时空释放醋酸炔诺酮的新型宫内节育器,作为绝经泌尿生殖综合征的抗雌激素干预措施。
Pharmaceutics. 2024 Apr 26;16(5):587. doi: 10.3390/pharmaceutics16050587.
5
Migration of Intra-Uterine Devices.宫内节育器的移位
Open Access J Contracept. 2024 Mar 12;15:41-47. doi: 10.2147/OAJC.S458156. eCollection 2024.
6
Photo Responsive Biodegradable Nanoparticle Forming Intrauterine Implant for Drug Delivery to Treat Ovarian Diseases: A Rationale-based Review.光响应可生物降解纳米颗粒形成宫内节育器用于治疗卵巢疾病的药物输送:基于原理的综述。
Curr Radiopharm. 2024;17(4):313-319. doi: 10.2174/0118744710258313231105072931.
7
What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device.我们学到了什么?激素宫内节育器共享学习议程和获取策略的实施。
Glob Health Sci Pract. 2022 Oct 31;10(5). doi: 10.9745/GHSP-D-21-00789.
8
Recent progress in advanced biomaterials for long-acting reversible contraception.长效可逆避孕先进生物材料的最新进展。
J Nanobiotechnology. 2022 Mar 17;20(1):138. doi: 10.1186/s12951-022-01329-5.
9
Migration of intrauterine device caused asymptomatic acute appendicitis: A case report.宫内节育器移位导致无症状性急性阑尾炎:一例报告
Clin Case Rep. 2021 May 24;9(5):e04283. doi: 10.1002/ccr3.4283. eCollection 2021 May.
10
Far-migration of an intrauterine device in the intrathoracic cavity: A rare case report.宫内节育器向胸腔内远距离迁移:1例罕见病例报告
Clin Case Rep. 2021 May 19;9(5):e04127. doi: 10.1002/ccr3.4127. eCollection 2021 May.

本文引用的文献

1
Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system.使用Liletta® 52毫克宫内节育系统5年的左炔诺孕酮释放率。
Contraception. 2016 Oct;94(4):353-6. doi: 10.1016/j.contraception.2016.04.010. Epub 2016 Apr 25.
2
Choice of Emergency Contraceptive and Decision Making Regarding Subsequent Unintended Pregnancy.紧急避孕药的选择及关于后续意外怀孕的决策
J Womens Health (Larchmt). 2016 Oct;25(10):1038-1043. doi: 10.1089/jwh.2015.5625. Epub 2016 Mar 31.
3
Reproductive Life Planning and Preconception Care 2015: Attitudes of English-Speaking Family Planning Patients.2015年生殖生活规划与孕前保健:英语国家计划生育患者的态度
J Womens Health (Larchmt). 2016 Aug;25(8):832-9. doi: 10.1089/jwh.2015.5323. Epub 2016 Mar 14.
4
Declines in Unintended Pregnancy in the United States, 2008-2011.2008 - 2011年美国意外怀孕率下降情况
N Engl J Med. 2016 Mar 3;374(9):843-52. doi: 10.1056/NEJMsa1506575.
5
Comparison of Therapeutic Efficacies of Norethisterone, Tranexamic Acid and Levonorgestrel-Releasing Intrauterine System for the Treatment of Heavy Menstrual Bleeding: A Randomized Controlled Study.炔诺酮、氨甲环酸和左炔诺孕酮宫内节育系统治疗月经过多的疗效比较:一项随机对照研究。
Gynecol Obstet Invest. 2016;81(5):447-53. doi: 10.1159/000443393. Epub 2016 Mar 8.
6
Intrauterine systems: a frameless future?宫内节育系统:无框架的未来?
Expert Opin Drug Deliv. 2016 Jun;13(6):911-8. doi: 10.1517/17425247.2016.1162153. Epub 2016 Mar 25.
7
Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.口服左炔诺孕酮用于紧急避孕并同时放置左炔诺孕酮宫内节育器的偏好性和有效性:一项前瞻性队列研究。
Contraception. 2016 Jun;93(6):526-32. doi: 10.1016/j.contraception.2016.01.009. Epub 2016 Mar 2.
8
Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.52毫克左炔诺孕酮宫内节育器在经产妇女中的安全性和有效性:一项与TCu380A进行的7年随机对照研究。
Contraception. 2016 Jun;93(6):498-506. doi: 10.1016/j.contraception.2016.02.024. Epub 2016 Feb 23.
9
Development of a smart IUD launcher for prevention of uterine perforation.
Biomed Tech (Berl). 2016 Oct 1;61(5):551-556. doi: 10.1515/bmt-2015-0148.
10
Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.左炔诺孕酮宫内缓释系统治疗子宫内膜增生:一项韩国妇科肿瘤学组研究
Int J Gynecol Cancer. 2016 May;26(4):711-5. doi: 10.1097/IGC.0000000000000669.